Associate, FDA Healthcare
About the role
Our Mergers & Acquisitions (M&A) Practice is globally recognized as a top-tier leader in both public and private M&A transactions. We deliver unparalleled legal services for complex corporate deals, offering strategic planning, due diligence, negotiation, and execution of mergers, acquisitions, divestitures, joint ventures, and other business combinations. Serving a diverse clientele, including multinational corporations, private equity firms and banks, our team ensures regulatory compliance, manages risk, and structures transactions for optimal outcomes. By combining extensive legal expertise with deep market insight, we help clients navigate high-stakes transactions, fostering growth and creating value, solidifying our reputation as one of the premier M&A practices worldwide. Position Summary We are seeking a mid-level associate with FDA, healthcare regulatory, life sciences transactional or related regulatory experience to join our FDA Healthcare practice in the New York office. The associate will support a regulatory partner whose practice integrates FDA-regulated product counseling, healthcare compliance, commercial contracting, corporate transactions, enforcement risk management and cross-border strategy. The role will involve advising global life sciences, healthcare, technology and investor clients on complex regulatory matters affecting drugs, biologics, medical devices, diagnostics, digital health technologies, cosmetics, food and tobacco products. Matters will also span healthcare regulatory regimes involving reimbursement, provider operations, telemedicine, pharmacy regulation, laboratory oversight, DEA compliance and privacy. The ideal candidate will combine strong transactional judgment with a practical understanding of the FDA and healthcare regulatory framework. Candidates should have excellent drafting, analytical, research, organizational, and project-management skills, as well as the ability to communicate complex regulatory considerations clearly and commercially to clients and deal teams